Ocular Pharmacokinetics of Tobramycin. A Comparative Radioimmunoassay and Microbiological Assay

Overview

Journal Int Ophthalmol

Specialty Ophthalmology

Date 1993 Aug 1

PMID 8112967

Citations 2

Authors

S Desai

Affiliations

Soon will be listed here.

Abstract

The ocular pharmacokinetics of tobramycin were studied in human and rabbit eyes following topical and subconjunctival administration in humans and following intravitreal administration in rabbit eyes. Each aqueous and vitreous sample was analysed by radioimmunoassay and microbiological assay. Topical instillation of 0.3% eyedrops by a loading dose schedule provided rapid penetration of the drug into the aqueous humour with a peak titre of 3.24 mg/l (RIA) at 2-hour intervals and therapeutic levels up to 6 hours. A subconjunctivally administered standard dose of 20 mg/0.5 ml of the drug also showed rapid penetration in therapeutically effective concentration with a peak titre of 22.34 mg/l (RIA) and 16.80 mg/l (MBA) at 2-hour intervals and therapeutic levels of the drug remained up to 20 hours later. A study of vitreous clearance following the administration of a single intravitreal injection in rabbit eyes showed bioavailability of the drug at therapeutically effective levels for more than 72 hours. Mostly two, but sometimes only one sample at each time interval, were studied. Radioimmunoassay and microbiological assay results showed excellent correlation, with correlation coefficient > 0.90 at 1.0% level of probability.

Citing Articles

Impact of pH modification of the empirically used tobramycin ophthalmic solution on MIC90 concentration in tears and aqueous humor of donkeys (Equus asinus).

Ibrahim A, Abd-Elrasoul M, Sabra M BMC Vet Res. 2024; 20(1):218.

PMID: 38778405 PMC: 11112948. DOI: 10.1186/s12917-024-04072-1.

Pharmacokinetics of intravitreal antibiotics in endophthalmitis.

Radhika M, Mithal K, Bawdekar A, Dave V, Jindal A, Relhan N J Ophthalmic Inflamm Infect. 2015; 4:22.

PMID: 25667683 PMC: 4306439. DOI: 10.1186/s12348-014-0022-z.

References

Glasser D, Gardner S, Ellis J, Pettit T . Loading doses and extended dosing intervals in topical gentamicin therapy. Am J Ophthalmol. 1985; 99(3):329-32. DOI: 10.1016/0002-9394(85)90364-2. View

Okumoto M . Laboratory diagnosis of endophthalmitis. Int Ophthalmol Clin. 1987; 27(2):89-94. DOI: 10.1097/00004397-198702720-00005. View

Crowe C, Sanders E . Sisomicin: evaluation in vitro and comparison with gentamicin and tobramycin. Antimicrob Agents Chemother. 1973; 3(1):24-8. PMC: 444355. DOI: 10.1128/AAC.3.1.24. View

Peyman G, Vastine D, Raichand M . Experimental aspects and their clinical application. Ophthalmology. 1978; 85(4):374-85. DOI: 10.1016/s0161-6420(78)35659-1. View

Behrens-Baumann W, Martell J . Ciprofloxacin concentrations in human aqueous humor following intravenous administration. Chemotherapy. 1987; 33(5):328-30. DOI: 10.1159/000238517. View

Nelsen P, Peyman G, Bennett T . BB-K8: A new aminoglycoside for intravitreal injection in bacterial endophthalmitis. Am J Ophthalmol. 1974; 78(1):82-9. DOI: 10.1016/0002-9394(74)90013-0. View

Traub W, RAYMOND E . Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate. Appl Microbiol. 1972; 23(1):4-7. PMC: 380267. DOI: 10.1128/am.23.1.4-7.1972. View

Fisch A, Salvanet A, Prazuck T, Forestier F, Gerbaud L, Coscas G . Epidemiology of infective endophthalmitis in France. The French Collaborative Study Group on Endophthalmitis. Lancet. 1991; 338(8779):1373-6. View

Ellerhost B, Golden B, Jarudi N . Ocular penetration of topically applied gentamicin. Arch Ophthalmol. 1975; 93(5):371-8. DOI: 10.1001/archopht.1975.01010020383014. View

10.

Carney M, Peyman G . Vitrectomy in endophthalmitis. Int Ophthalmol Clin. 1987; 27(2):127-34. DOI: 10.1097/00004397-198702720-00010. View

11.

Waitz J, Moss Jr E, Drube C, Weinstein M . Comparative activity of sisomicin, gentamicin, kanamycin, and tobramycin. Antimicrob Agents Chemother. 1972; 2(6):431-7. PMC: 444335. DOI: 10.1128/AAC.2.6.431. View

12.

SLOAN S, Pettit T, Litwack K . Gentamicin penetration in the aqueous humor of eyes with corneal ulcers. Am J Ophthalmol. 1972; 73(5):750-3. DOI: 10.1016/0002-9394(72)90392-3. View

13.

Young P, Barza M, Kane A, Baum J . Radioactive and bioassay of intraocular antibiotics: double-assay technique to compare penicillin G, cefamandole, and gentamicin in ocular tissues in vivo. Arch Ophthalmol. 1979; 97(4):717-20. DOI: 10.1001/archopht.1979.01020010369019. View

14.

Dienstag J, Neu H . In vitro studies of tobramycin, an aminoglycoside antibiotic. Antimicrob Agents Chemother. 1972; 1(1):41-5. PMC: 444163. DOI: 10.1128/AAC.1.1.41. View

15.

FURGIUELE F . Ocular penetration and tolerance of gentamicin. Am J Ophthalmol. 1967; 64(3):421-6. DOI: 10.1016/0002-9394(67)92006-5. View

16.

Mikkelson T, Chrai S, Robinson J . Altered bioavailability of drugs in the eye due to drug-protein interaction. J Pharm Sci. 1973; 62(10):1648-53. DOI: 10.1002/jps.2600621014. View

17.

Richards A, Bron A, Rice N, Fells P, Marshall M, Jones B . Intraocular penetration of cephaloridine. Br J Ophthalmol. 1972; 56(7):531-6. PMC: 1208836. DOI: 10.1136/bjo.56.7.531. View

18.

Barza M, Kane A, Baum J . Regional differences in ocular concentration of gentamicin after subconjunctival and retrobulbar injection in the rabbit. Am J Ophthalmol. 1977; 83(3):407-13. DOI: 10.1016/0002-9394(77)90741-3. View

19.

Wingfield D, McDougal R, Roy F, Hanna C . Ocular penetration of amikacin following intramuscular injection. Arch Ophthalmol. 1983; 101(1):117-20. DOI: 10.1001/archopht.1983.01040010119022. View

20.

FURGIUELE F, Smith J, BARON J . Tobramycin levels in human eyes. Am J Ophthalmol. 1978; 85(1):121-3. DOI: 10.1016/s0002-9394(14)76677-2. View